Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2022 Feb 3;36(6):e460–e464. doi: 10.1111/jdv.17950

Figure 2.

Figure 2

Pairwise comparisons of acceptable days to delay treatment between specific circumstances (e.g. family or close friend, standard office or institution policy) for different presentations of BCC, cSCC and melanoma (ranging from least to greatest severity). The number in each box is the difference in the acceptable days to delay between the condition in the column as vs. the condition in the top row. Positive values indicate a greater number of days are acceptable in the column condition, whereas negative values indicate a fewer number of days are acceptable in the column condition. For example, for ‘BCC appropriate for surgical excision that is other than high risk’, the average number of acceptable days to delay treatment for a family member or close friend is 46 days less than for circumstances when PPE is not available. Abbreviations: BCC, basal cell carcinoma; cSCC, cutaneous squamous cell carcinoma.